GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
This Quarter Return
+4.43%
1 Year Return
-11.97%
3 Year Return
+36.42%
5 Year Return
+73.97%
10 Year Return
–
AUM
$2.26B
AUM Growth
+$2.26B
(+5.5%)
Cap. Flow
+$69M
Cap. Flow
% of AUM
3.05%
Top 10 Holdings %
Top 10 Hldgs %
23.68%
Holding
567
New
17
Increased
153
Reduced
165
Closed
110
Top Buys
| 1 |
Perrigo
PRGO
|
$4.2M |
| 2 |
Verizon
VZ
|
$3.94M |
| 3 |
ASML
ASML
|
$3M |
| 4 |
Occidental Petroleum
OXY
|
$2.96M |
| 5 |
Boeing
BA
|
$2.41M |
Top Sells
| 1 |
Vodafone
VOD
|
$2.81M |
| 2 |
Globus Medical
GMED
|
$2.46M |
| 3 |
NOV
NOV
|
$2.35M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$2.2M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$1.55M |
Sector Composition
| 1 | Healthcare | 16.02% |
| 2 | Technology | 11.84% |
| 3 | Industrials | 11.52% |
| 4 | Financials | 10.85% |
| 5 | Consumer Staples | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$2.79T
| $21M | 0.93% |
725,025
+6,502
| +0.9% | +$188K |
|
27
Gilead Sciences
GILD
$140B
| $20.8M | 0.92% |
251,071
+1,399
| +0.6% | +$116K |
|
|
AGN
28
DELISTED
ALLERGAN INC
AGN
| $20.7M | 0.91% |
122,372
-13,005
| -10% | -$2.2M |
|
|
29
Boeing
BA
$176B
| $20.6M | 0.91% |
161,723
+18,934
| +13% | +$2.41M |
|
30
Ecolab
ECL
$77.5B
| $20.5M | 0.9% |
184,008
-875
| -0.5% | -$97.4K |
|
31
Caterpillar
CAT
$194B
| $19.8M | 0.87% |
182,184
-4,072
| -2% | -$443K |
|
32
MetLife
MET
$53.6B
| $19.7M | 0.87% |
398,203
-1,076
| -0.3% | -$53.3K |
|
|
33
Verizon
VZ
$184B
| $19.7M | 0.87% |
402,700
+80,588
| +25% | +$3.94M |
|
34
Honeywell
HON
$136B
| $19.5M | 0.86% |
219,718
+783
| +0.4% | +$69.4K |
|
|
EMC
35
DELISTED
EMC CORPORATION
EMC
| $18.8M | 0.83% |
715,109
-5,572
| -0.8% | -$147K |
|
36
National Grid
NGG
$68B
| $18.7M | 0.83% |
257,181
-5,536
| -2% | -$403K |
|
37
SPDR S&P 500 ETF Trust
SPY
$656B
| $18.6M | 0.82% |
95,145
-4,783
| -5% | -$936K |
|
|
DD
38
DELISTED
Du Pont De Nemours E I
DD
| $17.4M | 0.77% |
279,708
+1,744
| +0.6% | +$108K |
|
39
Merck
MRK
$210B
| $17.2M | 0.76% |
311,494
+2,753
| +0.9% | +$152K |
|
40
3M
MMM
$81B
| $16.7M | 0.74% |
139,474
+425
| +0.3% | +$50.9K |
|
41
iShares MSCI Emerging Markets ETF
EEM
$19B
| $15.8M | 0.7% |
365,853
-30,907
| -8% | -$1.34M |
|
|
UN
42
DELISTED
Unilever NV New York Registry Shares
UN
| $15.6M | 0.69% |
357,453
+3,366
| +1% | +$147K |
|
43
Berkshire Hathaway Class B
BRK.B
$1.08T
| $15.6M | 0.69% |
123,376
-155
| -0.1% | -$19.6K |
|
44
AbbVie
ABBV
$374B
| $15M | 0.66% |
265,171
-17,038
| -6% | -$962K |
|
45
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $14.5M | 0.64% |
335,536
-6,630
| -2% | -$286K |
|
46
Abbott
ABT
$230B
| $14.3M | 0.63% |
349,749
+39,552
| +13% | +$1.62M |
|
47
Philip Morris
PM
$254B
| $14.3M | 0.63% |
169,456
-13,867
| -8% | -$1.17M |
|
48
iShares MSCI EAFE ETF
EFA
$65.4B
| $14.2M | 0.63% |
207,072
-997
| -0.5% | -$68.2K |
|
49
Wells Fargo
WFC
$258B
| $13.7M | 0.61% |
261,293
-2,165
| -0.8% | -$114K |
|
50
Pfizer
PFE
$141B
| $13.6M | 0.6% |
481,656
+12,541
| +3% | +$353K |
|